Top Markets
#1 Ontology Gas Ontology Gas +31.11%
#2 Verus Coin Verus Coin +22.50%
#3 Status Status +21.81%
#4 Bitway Bitway +15.86%
#5 Geodnet Geodnet +14.89%
#6 ETHGas ETHGas +13.90%
#7 The Black Bull The Black Bull +11.57%
#8 Curve DAO Curve DAO +11.06%
#9 Fake World Assets Fake World Assets +10.89%
#10 Pons Pons +10.78%
Coin of the day
Ontology Gas Ontology Gas
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
PharmGen Science, Inc. PharmGen Science, Inc.

PharmGen Science, Inc.

004720
Clasificación en acciones #25692
PharmGen Science, Inc., originally founded in 1961 as Wooridul Pharmaceutical... PharmGen Science, Inc., originally founded in 1961 as Wooridul Pharmaceutical Limited, is a South Korean company primarily involved in the research, development, manufacturing, and distribution of pharmaceutical products. Based in Hwaseong, South Korea, the firm offers a diverse portfolio encompassing prescription medications, over-the-counter drugs, nutritional supplements, and cosmetic items. These are available in various forms, including tablets, hard capsules, granules, ointments, syrups, and suspensions.
Precio por acción
$2.13
Capitalización bursátil
$46.67M
Cambio (1 día)
-3.75%
Cambio (1 año)
-33.04%
País
KR
Comercio PharmGen Science, Inc. (004720)

Categoría

Healthcare
Ganancias de PharmGen Science, Inc. (004720)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di PharmGen Science, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de PharmGen Science, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US